You may have heard of Ozempic, and other GLP-1 drugs. They’re everywhere. And they typically involve weekly injections — which can have a sticker price of over a thousand dollars a month. And insurance coverage has been tricky to navigate for a lot of people. That’s why there’s a lot of excitement around a new pill form of the drug. NPR Pharmaceuticals Correspondent Sydney Lupkin chats about these experimental pills with host Emily Kwong. 


Check out more of NPR’s coverage about GLP-1s.


Interested in more health stories? Email us your question at [email protected].


Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.

To manage podcast ad preferences, review the links below:

See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy